Skip to main content

Articles

Page 78 of 78

  1. We previously reported the usefulness of the αGal epitope as a target molecule for gene therapy against cancer. To induce cancer cell specific transcription of the αGal epitope, an expression vector which synt...

    Authors: Tokihiko Sawada, Osamu Yamada, Naoko Yoshimura, Keiko Hatori, Shohei Fuchinoue and Satoshi Teraoka
    Citation: Cancer Cell International 2002 2:14
  2. A kinetic model has been developed to study cancer growth. Cancer growth has been considered as interaction between various independent but interacting compartments. The model considers cell growth and metasta...

    Authors: Siddhartha Jain
    Citation: Cancer Cell International 2002 2:13
  3. The C1D gene is expressed in a broad spectrum of mammalian cells and tissues but its product induces apoptotic cell death when exceeding a critical level. Critical levels are achieved in a fraction of cells by...

    Authors: Karsten Rothbarth, Hermann Stammer and Dieter Werner
    Citation: Cancer Cell International 2002 2:12
  4. It is postulated that the unusual manifestations of Kaposis's sarcoma cells in nonendothelial brain tissues and on eyeballs in advanced acquired immune deficiency syndrome (AIDS) cases are metastasized AIDS-Ka...

    Authors: Mahruf U Rahman and Amitabha Mazumder
    Citation: Cancer Cell International 2002 2:11
  5. Supplementing mice with high levels of dietary n-3 polyunsaturated fatty acids (PUFAs) increases the n-3 PUFAs in cell membranes, increases the susceptibility of the cells for lipid peroxidation (LPO) and decr...

    Authors: W Elaine Hardman, Jesus Munoz Jr and Ivan L Cameron
    Citation: Cancer Cell International 2002 2:10
  6. Isopeptides (ε-peptides) of lysine, with a given Mw and low polydispersity (10–400 units), were synthesized to study the relationship between their chemical structure and biological effect. The designed compou...

    Authors: B Szende, Gy Szökán, E Tyihá, K Pál, R Gáborjányi, M Almás and A R Khlafulla
    Citation: Cancer Cell International 2002 2:4
  7. The issue remains unresolved as to whether low frequency magnetic fields can affect cell behaviour, with the possibility that they may be in part responsible for the increased incidence of leukaemia in parts o...

    Authors: Paul A Harris, Justin Lamb, Brian Heaton and Denys N Wheatley
    Citation: Cancer Cell International 2002 2:3
  8. The p16INK4A gene product halts cell proliferation by preventing phosphorylation of the Rb protein. The p16INK4a gene is often deleted in human glioblastoma multiforme, contributing to unchecked Rb phosphorylatio...

    Authors: Bryan E Strauss, Ricardo BV Fontes, Claudimara FP Lotfi, Ana Lucia Skorupa, Ione Bartol, José Cipolla-Neto and Eugenia Costanzi-Strauss
    Citation: Cancer Cell International 2002 2:2
  9. We describe an alternative method to determine mRNA half-life (t1/2) based on the Real-Time RT-PCR procedure. This approach was evaluated by using the β-actin gene as a reference molecule for measuring of mRNA st...

    Authors: Guy J Leclerc, Gilles M Leclerc and Julio C Barredo
    Citation: Cancer Cell International 2002 2:1
  10. 5-AzaCytidine (AzaC) is a DNA demethylating drugs that has been shown to inhibit cell growth and to induce apoptosis in certain cancer cells. Induced expression of the galectin1 (Gal1) protein, a galactoside-b...

    Authors: Florence Poirier, Philippe Bourin, Dominique Bladier, Raymonde Joubert-Caron and Michel Caron
    Citation: Cancer Cell International 2001 1:2
  11. Mitotic death is a delayed response of p53 mutant tumours that are resistant to genotoxic damage. Questions surround why this response is so delayed and how its mechanisms serve a survival function. After unco...

    Authors: Jekaterina Erenpreisa and M S Cragg
    Citation: Cancer Cell International 2001 1:1

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 5.3
    5-year Journal Impact Factor: 5.0
    Source Normalized Impact per Paper (SNIP): 0.920
    SCImago Journal Rank (SJR): 1.257

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 110

    Usage 2023
    Downloads: 2,067,719
    Altmetric mentions: 1,052

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here